Acurx Pharmaceuticals(ACXP.US)

Last Updated 19:00:00 ET
longbridge loading

07:01 ETAcurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update

prnewswire·
US
ACXP
-4.85%
US
BBH
-0.17%
US
ARKG
-0.53%
prnewswire·
US
ACXP
-4.85%
US
BBH
-0.17%
US
ARKG
-0.53%

Acurx Pharmaceuticals | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
ACXP
-4.85%
Earnings Watch·
US
ACXP
-4.85%

ACXP Q1'26 Earnings: EPS estimate is (1.20) USD

TradingView·
US
ACXP
-4.85%
US
BBH
-0.17%
US
PBE
-0.85%
TradingView·
US
ACXP
-4.85%
US
BBH
-0.17%
US
PBE
-0.85%

Acura Pharmaceuticals Secures Insider Loans Amid Liquidity Strain

Tip Ranks·
US
ACXP
-4.85%
US
VRTX
-0.03%
US
IBBQ
+0.24%
Tip Ranks·
US
ACXP
-4.85%
US
VRTX
-0.03%
US
IBBQ
+0.24%

Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | ACXP Stock News

StockTitan·
US
ACXP
-4.85%
US
PBE
-0.85%
US
SBIO
+1.29%
StockTitan·
US
ACXP
-4.85%
US
PBE
-0.85%
US
SBIO
+1.29%

Acurx Pharmaceuticals shares are trading lower after the company announced a $7.1 million registered direct offering.

benzinga_article·
US
ACXP
-4.85%
US
IHE
-0.34%
US
XLV
-0.18%
benzinga_article·
US
ACXP
-4.85%
US
IHE
-0.34%
US
XLV
-0.18%
© 2026 Longbridge｜Disclaimer